Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing

Genome Research

Volumn 24, Issue 7, 2014, Pages 1053-1063

  Helman, Elena ^a,b   Lawrence, Michael S ^b   Stewart, Chip ^b   Sougnez, Carrie ^b   Getz, Gad ^b,c   Meyerson, Matthew ^a,b,d,e  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RETROPOSON; TRANSPOSON;

ARTICLE; COLORECTAL CARCINOMA; DNA TRANSPOSITION; ENDOMETRIUM CARCINOMA; EXOME; EXON; GENE INSERTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSDUCTION; GENOME; GENOMICS; HEAD AND NECK CARCINOMA; HUMAN; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; NEOPLASM; PRIORITY JOURNAL; RETROPOSON; SOMATIC MUTATION; TUMOR GENE; TUMOR SUPPRESSOR GENE; BIOLOGY; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; NUCLEIC ACID DATABASE; NUCLEOTIDE SEQUENCE; PROCEDURES; TRANSPOSON;

BASE SEQUENCE; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; DNA TRANSPOSABLE ELEMENTS; EXOME; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTAGENESIS, INSERTIONAL; NEOPLASMS; RETROELEMENTS; SEQUENCE ANALYSIS, DNA;

EID: 84904247696     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.163659.113     Document Type: Article

References (71)

1. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, Clementi L, Ren J, Li WW, Noble WS. 2009. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res 37: W202-W208.
2. Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L, et al. 2012. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486: 405-409.
3. Bass AJ, Lawrence MS, Brace LE, Ramos AH, Drier Y, Cibulskis K, Sougnez C, Voet D, Saksena G, Sivachenko A, et al. 2011. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet 43: 964-968.
4. Beck CR, Collier P, Macfarlane C, Malig M, Kidd JM, Eichler EE, Badge RM, Moran JV. 2010. LINE-1 retrotransposition activity in human genomes. Cell 141: 1159-1170.
5. Belgnaoui SM, Gosden RG, Semmes OJ, Haoudi A. 2006. Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells. Cancer Cell Int 6: 13.
6. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, et al. 2007. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci 104: 20007-20012.
7. Brondello J-M, Pillaire MJ, Rodriguez C, Gourraud P-A, Selves J, Cazaux C, Piette J. 2008. Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol z. Oncogene 27: 6093-6101.
8. Brouha B, Meischl C, Ostertag E, de Boer M, Zhang Y, Neijens H, Roos D, Kazazian HH. 2002. Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am J Hum Genet 71: 327-336. (Pubitemid 34800249)
9. Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, Kazazian HH. 2003. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci 100: 5280-5285. (Pubitemid 36542696)
10. Burns KH, Boeke JD. 2012. Human Transposon Tectonics. Cell 149: 740-752.
11. Carneiro MO, Russ C, Ross MG, Gabriel SB, Nusbaum C, DePristo MA. 2012. Pacific biosciences sequencing technology for genotyping and variation discovery in human data. BMC Genomics 13: 375.
12. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet J-P, Ahmann GJ, Adli M, et al. 2011. Initial genome sequencing and analysis of multiple myeloma. Nature 471: 467-472.
13. ChenCL, Rappailles A, Duquenne L, Huvet M, Guilbaud G, Farinelli L, Audit B, d'Aubenton-Carafa Y, Arneodo A, Hyrien O, et al. 2010. Impact of replication timing on non-CpG and CpG substitution rates in mammalian genomes. Genome Res 20: 447-457.
14. Cordaux R, Batzer MA. 2009. The impact of retrotransposons on human genome evolution. Nat Rev Genet 10: 691-703.
15. Cost GJ, Golding A, Schlissel MS, Boeke JD. 2001. Target DNA chromatinization modulates nicking by L1 endonuclease. Nucleic Acids Res 29: 573-577. (Pubitemid 32060943)
16. Cost GJ, Feng Q, Jacquier A, Boeke JD. 2002. Human L1 element target-primed reverse transcription in vitro. EMBO J 21: 5899-5910. (Pubitemid 35315287)
17. Dulak AM, Schumacher SE, van Lieshout J, Imamura Y, Fox C, Shim B, Ramos AH, Saksena G, Baca SC, Baselga J, et al. 2012. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res 72: 4383-4393.
18. Ewing AD, Kazazian HH. 2010. High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res 20: 1262-1270.
19. Ewing AD, Kazazian HH. 2011. Whole-genome resequencing allows detection of many rare LINE-1 insertion alleles in humans. Genome Res 21: 985-990.
20. Feng Q, Moran JV, KazazianHH, Boeke JD. 1996. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 87: 905-916. (Pubitemid 26404289)
21. Fungtammasan A, Walsh E, Chiaromonte F, Eckert KA, Makova KD. 2012. A genome-wide analysis of common fragile sites: What features determine chromosomal instability in the human genome? Genome Res 22: 993-1005.
22. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, ViglioneM, Symer DE, et al. 2000. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720. (Pubitemid 30365531)
23. Goodier JL, Ostertag EM, Kazazian HH. 2000. Transduction of 3′-flanking sequences is common in L1 retrotransposition. Hum Mol Genet 9: 653-657. (Pubitemid 30154024)
24. GrabherrMG, Haas BJ, Yassour M, Levin JZ, Thompson DA, Amit I, Adiconis X, Fan L, Raychowdhury R, Zeng Q, et al. 2011. Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat Biotechnol 29: 644-652.
25. Hancks DC, Kazazian HH Jr. 2012. Active human retrotransposons: variation and disease. Curr Opin Genet Dev 22: 191-203.
26. Helman E, Meyerson M. 2011a. RetroSeq: A tool to discover somatic insertion of retrotransposons, Elena Helman, TCGA Scientific Symposium. http://cancergenome.nih.gov/newsevents/multimedialibrary/videos/retroseqhelman (Accessed June 4, 2013).
27. Helman E, Meyerson M. 2011b. Translation of theCancer Genome Program. http://www.aacr.org/home/scientists/meetings-workshops/specialconferences/ previous-special-conferences/2011-2012-specialconferences/translation-of-the- cancer-genome/program.aspx (Accessed June 7, 2013).
28. Holmes SE, Dombroski BA, Krebs CM, Boehm CD, Kazazian HH. 1994. A new retrotransposable human L1 element from the LRE2 locus on chromosome 1q produces a chimaeric insertion. Nat Genet 7: 143-148. (Pubitemid 24174651)
29. Hormozdiari F, Hajirasouliha I, Dao P, Hach F, Yorukoglu D, Alkan C, Eichler EE, Sahinalp SC. 2010. Next-generation VariationHunter: combinatorial algorithms for transposon insertion discovery. Bioinformatics 26: i350-i357.
30. Huang CRL, Schneider AM, Lu Y, Niranjan T, Shen P, Robinson MA, Steranka JP, Valle D, Civin CI, Wang T, et al. 2010. Mobile interspersed repeats are major structural variants in the human genome. Cell 141: 1171-1182.
31. Iskow RC, McCabeMT, Mills RE, Torene S, Pittard WS, Neuwald AF, Van Meir EG, Vertino PM, Devine SE. 2010. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141: 1253-1261.
32. Jurka J. 1997. Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc Natl Acad Sci 94: 1872-1877. (Pubitemid 27113929)
33. Kazazian HH. 2004. Mobile elements: Drivers of genome evolution. Science 303: 1626-1632.
34. Keane TM, Wong K, Adams DJ. 2013. RetroSeq: transposable element discovery from next-generation sequencing data. Bioinformatics 29: 389-390.
35. Kimberland ML, Divoky V, Prchal J, Schwahn U, Berger W, Kazazian HH. 1999. Full-length human L1 insertions retain the capacity for high frequency retrotransposition in cultured cells. Hum Mol Genet 8: 1557-1560. (Pubitemid 29374091)
36. Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, Fulton LL, Dooling DJ, Ding L, Mardis ER, et al. 2012. Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
37. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921.
38. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
39. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, et al. 2013. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499: 214-218.
40. Lebeau A, Grob TJ, Holst F, Seyedi-Fazlollahi N, Moch H, Terracciano L, Turzynski A, Choschzick M, Sauter G, Simon R. 2008. Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions. J Pathol 216: 151-157.
41. Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ, Lohr JG, Harris CC, Ding L, Wilson RK, et al. 2012. Landscape of somatic retrotransposition in human cancers. Science 337: 967-971.
42. Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, Amit I, Lajoie BR, Sabo PJ, Dorschner MO, et al. 2009. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326: 289-293.
43. Luan DD, Eickbush TH. 1995. RNA template requirements for target DNA-primed reverse transcription by the R2 retrotransposable element. Mol Cell Biol 15: 3882-3891.
44. Luan DD, Korman MH, Jakubczak JL, Eickbush TH. 1993. Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell 72: 595-605. (Pubitemid 23077747)
45. Meischl C, Boer M, Ahlin A, Roos D. 2000. A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease. Eur J Hum Genet 8: 697-703.
46. Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, et al. 2012. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 41: D64-D69.
47. Meyerson M, Gabriel S, Getz G. 2010. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11: 685-696.
48. Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, KinzlerKW, Vogelstein B, Nakamura Y. 1992. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 52: 643-645.
49. Moran JV, Holmes SE, Naas TP, DeBerardinis RJ, Boeke JD, Kazazian HH. 1996. High frequency retrotransposition in cultured mammalian cells. Cell 87: 917-927. (Pubitemid 26404290)
50. Moran JV, DeBerardinis RJ, Kazazian HH. 1999. Exon shuffling by L1 retrotransposition. Science 283: 1530-1534.
51. Morrish TA, Gilbert N, Myers JS, Vincent BJ, Stamato TD, Taccioli GE, Batzer MA, Moran JV. 2002. DNA repair mediated by endonucleaseindependent LINE-1 retrotransposition. Nat Genet 31: 159-165.
52. Morse B, Rotherg PG, South VJ, Spandorfer JM, Astrin SM. 1988. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 333: 87-90.
53. Ostertag EM, Kazazian HH. 2001. Biology of mammalian L1 retrotransposons. Annu Rev Genet 35: 501-538. (Pubitemid 34032985)
54. Penzkofer T. 2004. L1Base: from functional annotation to prediction of active LINE-1 elements. Nucleic Acids Res 33: D498-D500. (Pubitemid 40207923)
55. Pickeral OK, Makałowski W, Boguski MS, Boeke JD. 2000. Frequent human genomic DNA transduction driven by LINE-1 retrotransposition. Genome Res 10: 411-415.
56. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. 2011. Integrative genomics viewer. Nat Biotechnol 29: 24-26.
57. Rodić N, Burns KH. 2013. Long interspersed element-1 (LINE-1): passenger or driver in human neoplasms? PLoS Genet 9: e1003402.
58. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
59. Schwahn U, Lenzner S, Dong J, Feil S, Hinzmann B, van Duijnhoven G, Kirschner R, Hemberger M, Bergen AA, Rosenberg T, et al. 1998. Positional cloning of the gene for X-linked retinitis pigmentosa 2. Nat Genet 19: 327-332.
60. Shukla R, Upton KR, Muñoz-Lopez M, Gerhardt DJ, Fisher ME, Nguyen T, Brennan PM, Baillie JK, Collino A, Ghisletti S, et al. 2013. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 153: 101-111.
61. Silva FPG, Morolli B, Storlazzi CT, Anelli L, Wessels H, Bezrookove V, Kluin-Nelemans HC, Giphart-Gassler M. 2003. Identification of RUNX1/AML1 as a classical tumor suppressor gene. Oncogene 22: 538-547. (Pubitemid 36188611)
62. Solyom S, Ewing AD, Rahrmann EP, Doucet TT, Nelson HH, Burns MB, Harris RS, Sigmon DF, Casella A, Erlanger B, et al. 2012. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res 22: 2328-2338.
63. Stewart C, Kural D, Strömberg MP, Walker JA, Konkel MK, Stütz AM, Urban AE, Grubert F, Lam HYK, Lee W-P, et al. 2011. A comprehensive map of mobile element insertion polymorphisms in humans. PLoS Genet 7: e1002236.
64. Stratton MR, Campbell PJ, Futreal PA. 2009. The cancer genome. Nature 458: 719-724.
65. Szak ST, Pickeral OK, Makalowski W, Boguski MS, Landsman D, Boeke JD. 2002. Molecular archeology of L1 insertions in the human genome. Genome Biol 3: research0052.
66. van den Hurk JAJM, van de Pol DJR, Wissinger B, van Driel MA, Hoefsloot LH, deWijs IJ, van den Born LI, Heckenlively JR, Brunner HG, Zrenner E, et al. 2003. Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon. Hum Genet 113: 268-275. (Pubitemid 36992286)
67. Wang J, Song L, Grover D, Azrak S, Batzer MA, Liang P. 2006. dbRIP: a highly integrated database of retrotransposon insertion polymorphisms in humans. Hum Mutat 27: 323-329.
68. Witherspoon DJ, Xing J, Zhang Y, Watkins WS, Batzer MA, Jorde LB. 2010. Mobile element scanning (ME-Scan) by targeted high-throughput sequencing. BMC Genomics 11: 410.
69. Xing J, Zhang Y, Han K, Salem AH, Sen SK, Huff CD, Zhou Q, Kirkness EF, Levy S, Batzer MA, et al. 2009. Mobile elements create structural variation: analysis of a complete human genome. Genome Res 19: 1516-1526.
70. Zhang S, Chen H, Zhao X, Cao J, Tong J, Lu J, Wu W, Shen H, Wei Q, Lu D. 2013. REV3L 39UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility. Oncogene 32: 242-250.
71. Zingler N. 2005. Analysis of 5′ junctions of human LINE-1 and Alu retrotransposons suggests an alternative model for 5′-end attachment requiring microhomology-mediated end-joining. Genome Res 15: 780-789. (Pubitemid 41003101)